(1)
Ali Hammed, S.; Fadhil Alwan, A. Metastatic EGFR-Mutant Lung Adenocarcinoma Patients: A Safety and Efficacy Analysis of First- and Third-Generation EGFR-TKIs. MECOJ 2025, 1 (4), 20-25. https://doi.org/10.61706/MECOJ160189.